Sign In
Buy PROK
$1.73
-0.170 (-8.95%)
At Close: Jun 03, 2026
Trump's latest tariff threats and the impact on markets, ProKidney stock jumps over 500%
11:22am, Wednesday, 09'th Jul 2025
Morning Brief, Market Sunrise anchor Ramzan Karmali breaks down the latest international news for July 9, 2025. President Trump stated on a social media post that tariffs will start being paid on Augu
ProKidney: What's Happening With PROK Stock?
08:45am, Wednesday, 09'th Jul 2025
ProKidney Corp. (NASDAQ: PROK) has seen significant volatility following encouraging Phase 2 clinical trial outcomes for its REGEN-007 study, which assesses rilparencel in patients suffering from chro
ProKidney to Participate in the H.C. Wainwright 4th Annual Kidney Virtual Conference
07:30am, Wednesday, 09'th Jul 2025
WINSTON-SALEM, N.C., July 09, 2025 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company”), a leading late clinical-stage cellular therapeutics company focused on chr
Stock Market Today: PROK Soars 515% on Surging Volume Amid Clinical Trial Buzz
05:35pm, Tuesday, 08'th Jul 2025
ProKidney (PROK 513.36%) shares closed at $3.73, rising 515% today while the S&P 500 fell 0.1% and the Dow Jones Industrial Average dropped 0.4%.
ProKidney's stock rockets on ‘intriguing' news, but analyst doesn't recommend buying
05:09pm, Tuesday, 08'th Jul 2025
The stock of the day on Tuesday was ProKidney Corp.'s, as it was both the biggest gainer and the most actively traded on major U.S. exchanges, after the biotechnology company's diabetes treatment prod
Gold Falls 1%; ProKidney Shares Spike Higher
01:25pm, Tuesday, 08'th Jul 2025
U.S. stocks traded mixed midway through trading, with the Dow Jones index dipping more than 150 points on Tuesday.
Why Is Penny Stock ProKidney Trading Higher On Tuesday?
09:05am, Tuesday, 08'th Jul 2025
ProKidney Corp. PROK stock is trading higher on Tuesday, with a session volume of 39.8 million compared to the average volume of 1.12 million as per data from Benzinga Pro.
WINSTON-SALEM, N.C., July 08, 2025 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company"), a leading late clinical-stage cellular therapeutics company focused on chron
ProKidney Corp. Completes Domestication from the Cayman Islands to Delaware
12:43pm, Tuesday, 01'st Jul 2025
WINSTON-SALEM, N.C., July 01, 2025 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company"), a leading late clinical-stage cellular therapeutics company focused on chron
ProKidney Reports First Quarter 2025 Financial Results and Business Highlights
04:15pm, Monday, 12'th May 2025
WINSTON-SALEM, N.C., May 12, 2025 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company"), a leading late clinical-stage cellular therapeutics company focused on chroni
Down -38% in 4 Weeks, Here's Why You Should You Buy the Dip in PROKIDNEY CP (PROK)
10:55am, Friday, 21'st Mar 2025
PROKIDNEY CP (PROK) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revis
ProKidney Reports Full Year 2024 Financial Results and Business Highlights
07:30am, Monday, 17'th Mar 2025
WINSTON-SALEM, N.C., March 17, 2025 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney”), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease
Kuehn Law Encourages Investors of ProKidney Corp. to Contact Law Firm
11:08am, Friday, 31'st Jan 2025
NEW YORK , Jan. 31, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of ProKidney Corp. (NASDAQ: PROK) breached their fi
2025 Will Be A Major Year For ProKidney's Rilparencel In CKD Treatment
06:10am, Friday, 31'st Jan 2025
Rilparencel is ProKidney's main candidate. It is intended as a therapy that stabilizes kidneys, making it potentially useful for CKD patients. We'll have Rilparencel's Phase 2 full data in 2025, as we
ProKidney to Participate in Two Upcoming Conferences: Evercore HealthCONx Conference and the Citi Global Healthcare Conference
07:30am, Tuesday, 26'th Nov 2024
WINSTON-SALEM, N.C., Nov. 26, 2024 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney”), a late clinical-stage biotech company focused on the development of a first-in-class cell ther
